AI in Genomics and Epigenomics

Fishman, Veniamin; Sindeeva, Maria; Chekanov, Nikolay; Shashkova, Tatiana I.; Ivanisenko, Nikita V.; Kardymon, Olga L.

doi:10.1007/978-3-031-35176-1_11

Healthy Ageing and Longevity

2023

DOI: 10.1007/978-3-031-35176-1_11

|View full text |Cite

AI in Genomics and Epigenomics

Veniamin Fishman¹,

Maria Sindeeva²,

Nikolay Chekanov³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 109 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

The synergy of artificial intelligence and personalized medicine for the enhanced diagnosis, treatment, and prevention of disease

Zahra,

Al-Taher,

Alquhaidan

et al. 2024

Drug Metabolism and Personalized Therapy

View full text Add to dashboard Cite

Introduction The completion of the Human Genome Project in 2003 marked the beginning of a transformative era in medicine. This milestone laid the foundation for personalized medicine, an innovative approach that customizes healthcare treatments. Content Central to the advancement of personalized medicine is the understanding of genetic variations and their impact on drug responses. The integration of artificial intelligence (AI) into drug response trials has been pivotal in this domain. These technologies excel in handling large-scale genomic datasets and patient histories, significantly improving diagnostic accuracy, disease prediction and drug discovery. They are particularly effective in addressing complex diseases such as cancer and genetic disorders. Furthermore, the advent of wearable technology, when combined with AI, propels personalized medicine forward by offering real-time health monitoring, which is crucial for early disease detection and management. Summary The integration of AI into personalized medicine represents a significant advancement in healthcare, promising more accurate diagnoses, effective treatment plans and innovative drug discoveries. Outlook As technology continues to evolve, the role of AI in enhancing personalized medicine and transforming the healthcare landscape is expected to grow exponentially. This synergy between AI and healthcare holds great promise for the future, potentially revolutionizing the way healthcare is delivered and experienced.

show abstract

The synergy of artificial intelligence and personalized medicine for the enhanced diagnosis, treatment, and prevention of disease

Zahra,

Al-Taher,

Alquhaidan

et al. 2024

Drug Metabolism and Personalized Therapy

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

AI in Genomics and Epigenomics

Cited by 1 publication

References 109 publications

The synergy of artificial intelligence and personalized medicine for the enhanced diagnosis, treatment, and prevention of disease

The synergy of artificial intelligence and personalized medicine for the enhanced diagnosis, treatment, and prevention of disease

Contact Info

Product

Resources

About